Panamor – 75 Sr Tablets, Panamor-75 Injection, Panamor Suppositories-12,5 75,0 mg/ 12,5 mg/ 100,0 mg TABLETS, INJECTION, SUPPOSITORIES
PDF Leaflet Revision Date: 27 January 2023
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of pain and inflammation.
Dosage (summary)
Initial dose: 100-150 mg daily; adjust as needed.
Onset of Action / Duration
Onset: 30 mins, Duration: 6-8 hours
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Avoid in pregnancy after 20 weeks; contraindicated in lactation.
Key Drug Interactions
- Increased risk of GI bleeding with NSAIDs
- Increased lithium levels
- Increased digoxin levels
Contraindications
- Hypersensitivity to diclofenac
- Active GI bleeding
- Severe renal or hepatic failure
- Pregnancy after 30 weeks
Common side effects
- Gastrointestinal bleeding
- Nausea
- Headache
- Dizziness
Counselling Points
- Take with food to reduce GI upset
- Report any signs of bleeding
- Avoid alcohol to minimize GI risk
Serious warnings
- Increased risk of cardiovascular events
- GI toxicity
- Serious skin reactions
Important Disclaimer
The Panamor – 75 Sr Tablets, Panamor-75 Injection, Panamor Suppositories-12,5 75,0 mg/ 12,5 mg/ 100,0 mg TABLETS, INJECTION, SUPPOSITORIES professional information leaflet below is the property of Pharmacare and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
